Related references
Note: Only part of the references are listed.Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Emily Boorman et al.
PSYCHOPHARMACOLOGY (2016)
Therapeutic Potential of Cannabinoids in Psychosis
F. Markus Leweke et al.
BIOLOGICAL PSYCHIATRY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Targeting the Endocannabinoid System in Psychiatric Illness
Martin A. Katzman et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
The endocannabinoid system in guarding against fear, anxiety and stress
Beat Lutz et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Endocannabinoid signalling in reward and addiction
Loren H. Parsons et al.
NATURE REVIEWS NEUROSCIENCE (2015)
The endocannabinoid system modulates stress, emotionality, and inflammation
Molly S. Crowe et al.
BRAIN BEHAVIOR AND IMMUNITY (2014)
The Endocannabinoid/Endovanilloid System and Depression
Irena Smaga et al.
CURRENT NEUROPHARMACOLOGY (2014)
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness
Cecilia J. Hillard et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study
Carolin Hoyer et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
Experience Salience Gates Endocannabinoid Signaling at Hypothalamic Synapses
Jaclyn I. Wamsteeker Cusulin et al.
JOURNAL OF NEUROSCIENCE (2014)
Antidepressants and Changes in Concentration of Endocannabinoids and N-Acylethanolamines in Rat Brain Structures
Irena Smaga et al.
NEUROTOXICITY RESEARCH (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations
Peter Rotheneichner et al.
NEURAL PLASTICITY (2014)
Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET
R. Lanzenberger et al.
MOLECULAR PSYCHIATRY (2013)
Electroconvulsive Therapy Induces Neurogenesis in Frontal Rat Brain Areas
Dragos Inta et al.
PLOS ONE (2013)
Endocannabinoid system and mood disorders: Priming a target for new therapies
Vincenzo Micale et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Is There Any Clinically Relevant Cannabinoid-Induced Analgesia?
Birgit Kraft
PHARMACOLOGY (2012)
Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study
Laura Kranaster et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)
The major central endocannabinoid directly acts at GABAA receptors
Erwin Sigel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants
Boris B. Gorzalka et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Impairments in Endocannabinoid Signaling and Depressive Illness
Matthew N. Hill et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats
A. Sartorius et al.
PHARMACOPSYCHIATRY (2009)
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
Matthew N. Hill et al.
PSYCHONEUROENDOCRINOLOGY (2009)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Serum endocannabinoid content is altered in females with depressive disorders: A preliminary report
M. N. Hill et al.
PHARMACOPSYCHIATRY (2008)
Regulation of axonal development by plasma membrane gangliosides
Jose Abad-Rodriguez et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders
KY Vinod et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2006)
Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims
BL Hungund et al.
MOLECULAR PSYCHIATRY (2004)
Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
A Giuffrida et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: Evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling
M Egertova et al.
NEUROSCIENCE (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
Share Paper
